In a statement, Ro said, "We are working to ensure patients have access to the most effective medications available and will continue to follow all applicable FDA rules and guidelines." The supply update "starts the clock on having unfettered market access to the patented drug" for companies like Hims & Hers and the broader compounding GLP-1 space, analysts at Leerink Partners wrote in a note to clients Friday morning
Addressing underlying health Issues: Sometimes, symptoms attributed to HPA axis dysregulation can be due to other underlying health issues, like thyroid disorders, iron-deficiency anemia, hidden infections, or depression, for example
Zinatullina, K.M., Kasaikina, O.T., Kuzmin, V.A., and Khrameeva, N.P., Russ
Another point that catches my attention is Indigos positioning around personal communication